Business
Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent
Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent
About this update from Telix Pharmaceuticals Limited
[{"type":"text","content":"Telix Pharmaceuticals Ltd has released a press release. View Attachment","length":254,"tagName":"div"}]